LON:RLM Realm Therapeutics (RLM) Share Price, News & Analysis → Dividend-like income from non-dividend stocks (From Unstoppable Prosperity) (Ad) Free RLM Stock Alerts GBX 11.50 0.00 (0.00%) (As of 03/26/2019) Add Compare Share Share Today's Range 11.50▼ 11.5050-Day Range 11.50▼ 11.5052-Week Range 5.80▼ 40Volume169,853 shsAverage Volume800,861 shsMarket Capitalization£13.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Realm Therapeutics alerts: Email Address Ad Unstoppable ProsperityDividend-like income from non-dividend stocksThis coming Wednesday @ 7 PM EST you're going to discover… How to find safe value in the stocks you already own with simple Cash Flow Trade Strategies.Click here to register for free. About Realm TherapeuticsRealm Therapeutics Plc, a biopharmaceutical company, focuses on developing therapies for the treatment of immune-mediated diseases in adults and children. Its product pipeline includes PRO22, a topical gel, which is conducting initial Phase II clinical studies for the treatment of atopic dermatitis. The company was formerly known as PuriCore plc and changed its name to Realm Therapeutics Plc in December 2016. Realm Therapeutics Plc was founded in 2016 and is headquartered in Malvern, Pennsylvania.Read More RLM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RLM Stock News HeadlinesMay 24, 2023 | washingtonpost.comA watery mythological realm is given flesh at the SmithsonianMarch 23, 2023 | bbc.co.ukDefence of the Realm Act (DORA)February 28, 2022 | investing.comRealm Therapeutics PLC ADR (RLM_old)See More Headlines Receive RLM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Realm Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:RLM Previous SymbolLON:PURI CUSIPN/A CIKN/A Webwww.realmtx.com Phone+1-484-3212700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio10.05 Quick Ratio9.96 Sales & Book Value Annual Sales£501,919.00 Price / Sales26.71 Cash FlowGBX 20.30 per share Price / Cash Flow0.57 Book ValueGBX 20.80 per share Price / Book0.55Miscellaneous Outstanding Shares116,562,000Free FloatN/AMarket Cap£13.40 million OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. John Alexander Martin (Age 51)CEO & Exec. Director Ms. Marella Thorell (Age 52)CFO, COO, Company Sec. & Exec. Director Dr. Christian Peters (Age 57)Chief Medical Officer Key CompetitorsSynairgenLON:SNGDestiny PharmaLON:DESTNetScientificLON:NSCIImmuPharmaLON:IMMBiVictriX TherapeuticsLON:BVXView All Competitors RLM Stock Analysis - Frequently Asked Questions How have RLM shares performed in 2024? Realm Therapeutics' stock was trading at GBX 11.50 on January 1st, 2024. Since then, RLM stock has increased by 0.0% and is now trading at GBX 11.50. View the best growth stocks for 2024 here. What other stocks do shareholders of Realm Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Realm Therapeutics investors own include Allena Pharmaceuticals (ALNA), AcelRx Pharmaceuticals (ACRX), Ampliphi Biosciences (APHB), Viking Therapeutics (VKTX), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS). How do I buy shares of Realm Therapeutics? Shares of RLM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:RLM) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersDividend-like income from non-dividend stocksUnstoppable ProsperityMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeThis could mean the end of the U.S dollar…Colonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaBill Clinton Backing Biden Replacement???The Freeport SocietyGold Set to EXPLODE!Gold Safe Exchange$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Realm Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.